Market Tracker

09/19 7:35am ET

Synageva BioPharma Corp (NASDAQ:GEVA)

64.57
Data as of Sep 18
 -0.04 / -0.06%
Today’s Change
44.54
Today|||52-Week Range
119.42
-0.23%
Year-to-Date
No recent news for Synageva BioPharma Corp.

Today’s Trading

Previous close64.61
Today’s open65.11
Day’s range-- - --
Volume248,407
Average volume (3 months)279,262
Market cap$2.1B
Dividend yield--
Data as of 09/18/2014

Growth & Valuation

Earnings growth (last year)-78.95%
Earnings growth (this year)-81.32%
Earnings growth (next 5 years)+36.00%
Revenue growth (last year)-10.57%
P/E ratioNM
Price/Sales135.92
Price/Book4.62

Competitors

 Today’s
change
Today’s
% change
XONIntrexon Corp+1.32+6.81%
OPHTOphthotech Corp-0.50-1.28%
HALOHalozyme Therapeutic...0.000.00%
NVAXNovavax Inc-0.11-2.40%
Data as of 09/18/2014

Financials

Next reporting dateNovember 4, 2014
EPS forecast (this quarter)-$1.65
Annual revenue (last year)$13.4M
Annual profit (last year)-$95.5M
Net profit margin-713.70%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Sanj K. Patel
Chief Financial Officer &
Senior Vice President
Carsten Boess
Corporate headquarters
Lexington, Massachusetts

Forecasts